Report Detail
COVID-19 Impact on Global Parenteral Drugs Market Insights, Forecast to 2026
- RnM4071332 |
- 22 June, 2020 |
- Global |
- 145 Pages |
- QYResearch |
- Pharma & Healthcare
Parenteral Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Parenteral Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Parenteral Drugs market is segmented into
LVP Drug
SVP Drug
Segment by Application, the Parenteral Drugs market is segmented into
Hospitals
Medical Centers
Others
Regional and Country-level Analysis
The Parenteral Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Parenteral Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Parenteral Drugs Market Share Analysis
Parenteral Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Parenteral Drugs business, the date to enter into the Parenteral Drugs market, Parenteral Drugs product introduction, recent developments, etc.
The major vendors covered:
Ostuka Pharmaceutical
Teva Pharmaceutical Industries
Kelun Pharma
Cook Pharmica
Patheon
BAG Healthcare
Beximco Pharma
Baxter Healthcare Corporation
B. Braun
Fresenius
Albert David
BML Parenteral Drugs
Pfizer (Hospira)
Pisa
Ozon Pharmaceuticals Ltd
Aspen Holdings
PSI Ltd
Wintac Limited
AXA Parenterals Ltd
Acebright
Southwest Pharmaceutical
Abbott
1 Study Coverage
- 1.1 Parenteral Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Parenteral Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Parenteral Drugs Market Size Growth Rate by Type
- 1.4.2 LVP Drug
- 1.4.3 SVP Drug
- 1.5 Market by Application
- 1.5.1 Global Parenteral Drugs Market Size Growth Rate by Application
- 1.5.2 Hospitals
- 1.5.3 Medical Centers
- 1.5.4 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Parenteral Drugs Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Parenteral Drugs Industry
- 1.6.1.1 Parenteral Drugs Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Parenteral Drugs Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Parenteral Drugs Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Parenteral Drugs Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Parenteral Drugs Market Size Estimates and Forecasts
- 2.1.1 Global Parenteral Drugs Revenue 2015-2026
- 2.1.2 Global Parenteral Drugs Sales 2015-2026
- 2.2 Parenteral Drugs Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Parenteral Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Parenteral Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Parenteral Drugs Competitor Landscape by Players
- 3.1 Parenteral Drugs Sales by Manufacturers
- 3.1.1 Parenteral Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Parenteral Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Parenteral Drugs Revenue by Manufacturers
- 3.2.1 Parenteral Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Parenteral Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Parenteral Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Parenteral Drugs Revenue in 2019
- 3.2.5 Global Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Parenteral Drugs Price by Manufacturers
- 3.4 Parenteral Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Parenteral Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Parenteral Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Parenteral Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Parenteral Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Parenteral Drugs Sales by Type (2015-2020)
- 4.1.2 Global Parenteral Drugs Revenue by Type (2015-2020)
- 4.1.3 Parenteral Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Parenteral Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Parenteral Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Parenteral Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Parenteral Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Parenteral Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Parenteral Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Parenteral Drugs Sales by Application (2015-2020)
- 5.1.2 Global Parenteral Drugs Revenue by Application (2015-2020)
- 5.1.3 Parenteral Drugs Price by Application (2015-2020)
- 5.2 Parenteral Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Parenteral Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Parenteral Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Parenteral Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Parenteral Drugs by Country
- 6.1.1 North America Parenteral Drugs Sales by Country
- 6.1.2 North America Parenteral Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Parenteral Drugs Market Facts & Figures by Type
- 6.3 North America Parenteral Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Parenteral Drugs by Country
- 7.1.1 Europe Parenteral Drugs Sales by Country
- 7.1.2 Europe Parenteral Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Parenteral Drugs Market Facts & Figures by Type
- 7.3 Europe Parenteral Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Parenteral Drugs by Region
- 8.1.1 Asia Pacific Parenteral Drugs Sales by Region
- 8.1.2 Asia Pacific Parenteral Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Parenteral Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Parenteral Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Parenteral Drugs by Country
- 9.1.1 Latin America Parenteral Drugs Sales by Country
- 9.1.2 Latin America Parenteral Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Parenteral Drugs Market Facts & Figures by Type
- 9.3 Central & South America Parenteral Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Parenteral Drugs by Country
- 10.1.1 Middle East and Africa Parenteral Drugs Sales by Country
- 10.1.2 Middle East and Africa Parenteral Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Parenteral Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Parenteral Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Ostuka Pharmaceutical
- 11.1.1 Ostuka Pharmaceutical Corporation Information
- 11.1.2 Ostuka Pharmaceutical Description, Business Overview and Total Revenue
- 11.1.3 Ostuka Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Ostuka Pharmaceutical Parenteral Drugs Products Offered
- 11.1.5 Ostuka Pharmaceutical Recent Development
- 11.2 Teva Pharmaceutical Industries
- 11.2.1 Teva Pharmaceutical Industries Corporation Information
- 11.2.2 Teva Pharmaceutical Industries Description, Business Overview and Total Revenue
- 11.2.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Teva Pharmaceutical Industries Parenteral Drugs Products Offered
- 11.2.5 Teva Pharmaceutical Industries Recent Development
- 11.3 Kelun Pharma
- 11.3.1 Kelun Pharma Corporation Information
- 11.3.2 Kelun Pharma Description, Business Overview and Total Revenue
- 11.3.3 Kelun Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Kelun Pharma Parenteral Drugs Products Offered
- 11.3.5 Kelun Pharma Recent Development
- 11.4 Cook Pharmica
- 11.4.1 Cook Pharmica Corporation Information
- 11.4.2 Cook Pharmica Description, Business Overview and Total Revenue
- 11.4.3 Cook Pharmica Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Cook Pharmica Parenteral Drugs Products Offered
- 11.4.5 Cook Pharmica Recent Development
- 11.5 Patheon
- 11.5.1 Patheon Corporation Information
- 11.5.2 Patheon Description, Business Overview and Total Revenue
- 11.5.3 Patheon Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Patheon Parenteral Drugs Products Offered
- 11.5.5 Patheon Recent Development
- 11.6 BAG Healthcare
- 11.6.1 BAG Healthcare Corporation Information
- 11.6.2 BAG Healthcare Description, Business Overview and Total Revenue
- 11.6.3 BAG Healthcare Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 BAG Healthcare Parenteral Drugs Products Offered
- 11.6.5 BAG Healthcare Recent Development
- 11.7 Beximco Pharma
- 11.7.1 Beximco Pharma Corporation Information
- 11.7.2 Beximco Pharma Description, Business Overview and Total Revenue
- 11.7.3 Beximco Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Beximco Pharma Parenteral Drugs Products Offered
- 11.7.5 Beximco Pharma Recent Development
- 11.8 Baxter Healthcare Corporation
- 11.8.1 Baxter Healthcare Corporation Corporation Information
- 11.8.2 Baxter Healthcare Corporation Description, Business Overview and Total Revenue
- 11.8.3 Baxter Healthcare Corporation Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Baxter Healthcare Corporation Parenteral Drugs Products Offered
- 11.8.5 Baxter Healthcare Corporation Recent Development
- 11.9 B. Braun
- 11.9.1 B. Braun Corporation Information
- 11.9.2 B. Braun Description, Business Overview and Total Revenue
- 11.9.3 B. Braun Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 B. Braun Parenteral Drugs Products Offered
- 11.9.5 B. Braun Recent Development
- 11.10 Fresenius
- 11.10.1 Fresenius Corporation Information
- 11.10.2 Fresenius Description, Business Overview and Total Revenue
- 11.10.3 Fresenius Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Fresenius Parenteral Drugs Products Offered
- 11.10.5 Fresenius Recent Development
- 11.1 Ostuka Pharmaceutical
- 11.1.1 Ostuka Pharmaceutical Corporation Information
- 11.1.2 Ostuka Pharmaceutical Description, Business Overview and Total Revenue
- 11.1.3 Ostuka Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Ostuka Pharmaceutical Parenteral Drugs Products Offered
- 11.1.5 Ostuka Pharmaceutical Recent Development
- 11.12 BML Parenteral Drugs
- 11.12.1 BML Parenteral Drugs Corporation Information
- 11.12.2 BML Parenteral Drugs Description, Business Overview and Total Revenue
- 11.12.3 BML Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 BML Parenteral Drugs Products Offered
- 11.12.5 BML Parenteral Drugs Recent Development
- 11.13 Pfizer (Hospira)
- 11.13.1 Pfizer (Hospira) Corporation Information
- 11.13.2 Pfizer (Hospira) Description, Business Overview and Total Revenue
- 11.13.3 Pfizer (Hospira) Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Pfizer (Hospira) Products Offered
- 11.13.5 Pfizer (Hospira) Recent Development
- 11.14 Pisa
- 11.14.1 Pisa Corporation Information
- 11.14.2 Pisa Description, Business Overview and Total Revenue
- 11.14.3 Pisa Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Pisa Products Offered
- 11.14.5 Pisa Recent Development
- 11.15 Ozon Pharmaceuticals Ltd
- 11.15.1 Ozon Pharmaceuticals Ltd Corporation Information
- 11.15.2 Ozon Pharmaceuticals Ltd Description, Business Overview and Total Revenue
- 11.15.3 Ozon Pharmaceuticals Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Ozon Pharmaceuticals Ltd Products Offered
- 11.15.5 Ozon Pharmaceuticals Ltd Recent Development
- 11.16 Aspen Holdings
- 11.16.1 Aspen Holdings Corporation Information
- 11.16.2 Aspen Holdings Description, Business Overview and Total Revenue
- 11.16.3 Aspen Holdings Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Aspen Holdings Products Offered
- 11.16.5 Aspen Holdings Recent Development
- 11.17 PSI Ltd
- 11.17.1 PSI Ltd Corporation Information
- 11.17.2 PSI Ltd Description, Business Overview and Total Revenue
- 11.17.3 PSI Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 PSI Ltd Products Offered
- 11.17.5 PSI Ltd Recent Development
- 11.18 Wintac Limited
- 11.18.1 Wintac Limited Corporation Information
- 11.18.2 Wintac Limited Description, Business Overview and Total Revenue
- 11.18.3 Wintac Limited Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 Wintac Limited Products Offered
- 11.18.5 Wintac Limited Recent Development
- 11.19 AXA Parenterals Ltd
- 11.19.1 AXA Parenterals Ltd Corporation Information
- 11.19.2 AXA Parenterals Ltd Description, Business Overview and Total Revenue
- 11.19.3 AXA Parenterals Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.19.4 AXA Parenterals Ltd Products Offered
- 11.19.5 AXA Parenterals Ltd Recent Development
- 11.20 Acebright
- 11.20.1 Acebright Corporation Information
- 11.20.2 Acebright Description, Business Overview and Total Revenue
- 11.20.3 Acebright Sales, Revenue and Gross Margin (2015-2020)
- 11.20.4 Acebright Products Offered
- 11.20.5 Acebright Recent Development
- 11.21 Southwest Pharmaceutical
- 11.21.1 Southwest Pharmaceutical Corporation Information
- 11.21.2 Southwest Pharmaceutical Description, Business Overview and Total Revenue
- 11.21.3 Southwest Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.21.4 Southwest Pharmaceutical Products Offered
- 11.21.5 Southwest Pharmaceutical Recent Development
- 11.22 Abbott
- 11.22.1 Abbott Corporation Information
- 11.22.2 Abbott Description, Business Overview and Total Revenue
- 11.22.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
- 11.22.4 Abbott Products Offered
- 11.22.5 Abbott Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Parenteral Drugs Market Estimates and Projections by Region
- 12.1.1 Global Parenteral Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Parenteral Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Parenteral Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Parenteral Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Parenteral Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Parenteral Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Parenteral Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Parenteral Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Parenteral Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Parenteral Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Parenteral Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Parenteral Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Parenteral Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Parenteral Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Parenteral Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Parenteral Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Parenteral Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Parenteral Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Parenteral Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Parenteral Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Parenteral Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Parenteral Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Parenteral Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Parenteral Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Parenteral Drugs. Industry analysis & Market Report on COVID-19 Impact on Global Parenteral Drugs is a syndicated market report, published as COVID-19 Impact on Global Parenteral Drugs Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Parenteral Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
